Have a personal or library account? Click to login
Auditory and Olfactory Deficits in Essential Tremor – Review of the Current Evidence Cover

Auditory and Olfactory Deficits in Essential Tremor – Review of the Current Evidence

Tremor and Other Hyperkinetic Movements
Volume 10 (2020): Issue 0
By: Yildizhan Sengul  
Open Access
|Jun 2020

References

  1. 1Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Movement Disorders. 2010; 5: 534–541. DOI: 10.1002/mds.22838
    Back to article
  2. 2Louis ED, Okun MS. It is time to remove the ‘benign’ from the essential tremor label. Parkinsonism & related disorders. 2011; 7: 516–520. DOI: 10.1016/j.parkreldis.2011.03.012
    Back to article
  3. 3Chandran V, Pal PK. Essential tremor: beyond the motor features. Parkinsonism & related disorders. 2012; 5: 407–413. DOI: 10.1016/j.parkreldis.2011.12.003
    Back to article
  4. 4Lombardi WJ, Woolston DJ, Roberts JW, Gross RE. Cognitive deficits in patients with essential tremor. Neurology. 2001; 5: 785–790. DOI: 10.1212/WNL.57.5.785
    Back to article
  5. 5Louis ED. “Essential tremor and the cerebellum.” Handbook of clinical neurology. 2018; 155: 245–258. Elsevier. DOI: 10.1016/B978-0-444-64189-2.00016-0
    Back to article
  6. 6Louis ED, et al. “Essential tremor associated with pathologic changes in the cerebellum.” Archives of neurology. 2006; 6: 1189–1193. DOI: 10.1001/archneur.63.8.1189
    Back to article
  7. 7Benito-Leon J, Labiano-Fontcuberta A. Linking essential tremor to the cerebellum: clinical evidence. The Cerebellum. 2016; 15(3): 253–262. DOI: 10.1007/s12311-015-0741-1
    Back to article
  8. 8Filip P, et al. “Linking essential tremor to the cerebellum: physiological evidence.” The Cerebellum. 2016: 15(6): 774–780. DOI: 10.1007/s12311-015-0740-2
    Back to article
  9. 9Cerasa A, Quattrone A. Linking essential tremor to the cerebellum—neuroimaging evidence. The Cerebellum. 2016; 3: 263–275. DOI: 10.1007/s12311-015-0739-8
    Back to article
  10. 10Murphy C. Olfactory and other sensory impairments in Alzheimer disease. Nature Reviews Neurology. 2019; 15: 11–24. DOI: 10.1038/s41582-018-0097-5
    Back to article
  11. 11Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988; 38: 1237–1244. DOI: 10.1212/WNL.38.8.1237
    Back to article
  12. 12Barresi M, Ciurleo R, Giacoppo S, Cuzzola VF, Celi D, Bramanti P, Marino S. Evaluation of olfactory dysfunction in neurodegenerative diseases. Journal of the neurological sciences. 2012; 323: 16–24. DOI: 10.1016/j.jns.2012.08.028
    Back to article
  13. 13Fortunato S, Forli F, Guglielmi V, De Corso E, Paludetti G, Berrettini S, Fetoni AR. A review of new insights on the association between hearing loss and cognitive decline in ageing. Acta Otorhinolaryngologica Italica. 2016; 36: 155–166.
    Back to article
  14. 14Davis A, McMahon CM, Pichora-Fuller KM, Russ S, Lin F, Olusanya BO, Chadha S, Tremblay KL. Aging and hearing health: the life-course approach. The Gerontologist. 2016; 56(Suppl_2): 256–267. DOI: 10.1093/geront/gnw033
    Back to article
  15. 15Musiek, FE, Baran, JA. The auditory system: Anatomy, physiology, and clinical correlates. Plural Publishing. 2018; 487.
    Back to article
  16. 16Celesia GG, Hickok G. (eds.). The human auditory system: fundamental organization and clinical disorders. Elsevier. 2015; 722.
    Back to article
  17. 17Bellis TJ, Bellis JD. Central auditory processing disorders in children and adults. In Handbook of clinical neurology. 2015; 129: 537–556. DOI: 10.1016/B978-0-444-62630-1.00030-5
    Back to article
  18. 18Davies RA. Audiometry and other hearing tests. In Handbook of clinical neurology. 2016; 137: 157–176. DOI: 10.1016/B978-0-444-63437-5.00011-X
    Back to article
  19. 19Baiduc RR, Poling GL, Hong O, Dhar S. Clinical measures of auditory function: the cochlea and beyond. Disease-a-month: DM. 2013; 594: 147–156. DOI: 10.1016/j.disamonth.2013.01.005
    Back to article
  20. 20Musiek FE, Chermak GD. Psychophysical and behavioral peripheral and central auditory tests. In Handbook of clinical neurology. 2015; 129: 313–332. DOI: 10.1016/B978-0-444-62630-1.00018-4
    Back to article
  21. 21Hardy CJ, Marshall CR, Golden HL, et al. Hearing and dementia. J Neurol. 2016; 263: 2339–2354. DOI: 10.1007/s00415-016-8208-y
    Back to article
  22. 22Gurgel RK, Ward PD, Schwartz S, Norton MC, Foster NL, Tschanz JT. Relationship of hearing loss and dementia: a prospective, population-based study. Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2014; 35: 775–781. DOI: 10.1097/MAO.0000000000000313
    Back to article
  23. 23Lin FR, Metter EJ, O’Brien RJ, Resnick SM, Zonderman AB, Ferrucci L. Hearing loss and incident dementia. Archives of neurology. 2011; 68: 214–220. DOI: 10.1001/archneurol.2010.362
    Back to article
  24. 24Swords GM, Nguyen LT, Mudar RA, Llano DA. Auditory system dysfunction in Alzheimer disease and its prodromal states: a review. Ageing research reviews. 2018; 44: 49–59. DOI: 10.1016/j.arr.2018.04.001
    Back to article
  25. 25Uchida Y, Sugiura S, Nishita Y, Saji N, Sone M, Ueda H. Age-related hearing loss and cognitive decline—The potential mechanisms linking the two. Auris Nasus Larynx. 2018; 46: 1–9. DOI: 10.1016/j.anl.2018.08.010
    Back to article
  26. 26Kim SY, Lim JS, Kong IG, Choi HG. Hearing impairment and the risk of neurodegenerative dementia: A longitudinal follow-up study using a national sample cohort. Sci Rep. 2018; 8: 15266–15274. DOI: 10.1038/s41598-018-33325-x
    Back to article
  27. 27Vitale C, Marcelli V, Allocca R, Santangelo G, Riccardi P, Erro R, Amboni M, Pellecchia MT, Cozzolino A, Longo K, Picillo M. Hearing impairment in Parkinson’s disease: expanding the nonmotor phenotype. Movement Disorders. 2012; 27: 1530–1535. DOI: 10.1002/mds.25149
    Back to article
  28. 28Folmer RL, Vachhani JJ, Theodoroff SM, Ellinger R, Riggins A. Auditory processing abilities of Parkinson’s disease patients. BioMed research international. 2017; 2017: 1–10. DOI: 10.1155/2017/2618587
    Back to article
  29. 29Lai SW, Liao KF, Lin CL, Lin CC, Sung FC. Hearing loss may be a non-motor feature of P arkinson’s disease in older people in Taiwan. European journal of neurology. 2014; 21: 752–757. DOI: 10.1111/ene.12378
    Back to article
  30. 30Profant O, Roth J, Bureš Z, Balogová Z, Lišková I, Betka J, Syka J. Auditory dysfunction in patients with Huntington’s disease. Clinical Neurophysiology. 2017; 128: 1946–1953. DOI: 10.1016/j.clinph.2017.07.403
    Back to article
  31. 31Barsottini OG, Pedroso JL, Martins CR, França MC, Albernaz PM. Deafness and Vestibulopathy in Cerebellar Diseases: a Practical Approach. The Cerebellum 2019; 1: 1–6. DOI: 10.1007/s12311-019-01042-4
    Back to article
  32. 32Zeigelboim BS, de Carvalho HA, Teive HA, Liberalesso PB, Jurkiewicz AL, da Silva Abdulmassih EM, Marques JM, Cordeiro ML. Central auditory processing in patients with spinocerebellar ataxia. Hear Res. 2015; 327: 235–244. DOI: 10.1016/j.heares.2015.07.006
    Back to article
  33. 33Zeigelboim BS, Teive HAG, Rosa MRD, Malisky JS, Fonseca VR, Marques JM, Liberalesso PB. The importance of central auditory evaluation in Friedreich’s ataxia. Arq Neuropsiquiatr. 2018; 76: 170–176. DOI: 10.1590/0004-282x20180008
    Back to article
  34. 34Petacchi A, Laird AR, Fox PT, Bower JM. Cerebellum and auditory function: An ALE meta-analysis of functional neuroimaging studies. Human brain mapping. 2005; 25: 118–128. DOI: 10.1002/hbm.20137
    Back to article
  35. 35Huffman RF, Henson OW, Jr. The descending auditory pathway and acousticomotor systems: connections with the inferior colliculus. Brain research reviews. 19901; 15: 295–323. DOI: 10.1016/0165-0173(90)90005-9
    Back to article
  36. 36Zeigelboim BS, Teive HA, Santos RS, Arruda WO, Jurkiewicz AL, Mengelberg H, França D, Marques JM. Audiological evaluation in spinocerebellar ataxia. In: CoDAS Sociedade Brasileira de Fonoaudiologia. 2013; 25: 351–357. DOI: 10.1590/S2317-17822013005000001
    Back to article
  37. 37Zeigelboim BS, Mesti JC, Fonseca VR, Faryniuk JH, Marques JM, Cardoso RC, Teive HA. Otoneurological Abnormalities in Patients with Friedreich’s Ataxia. International archives of otorhinolaryngology. 2017; 21: 79–85. DOI: 10.1055/s-0036-1572529
    Back to article
  38. 38Ondo WG, Sutton L, Vuong KD, Lai D, Jankovic J. Hearing impairment in essential tremor. Neurology. 2003; 61: 1093–1097. DOI: 10.1212/01.WNL.0000086376.40750.AF
    Back to article
  39. 39Louis ED, Borden S, Moskowitz CB. Essential tremor centralized brain repository: diagnostic validity and clinical characteristics of a highly selected group of essential tremor cases. Movement disorders: official journal of the Movement Disorder Society. 2005; 20: 1361–1365. DOI: 10.1002/mds.20583
    Back to article
  40. 40Benito-León J, Louis ED, Bermejo-Pareja F. Reported hearing impairment in essential tremor: a population-based case-control study. Neuroepidemiolog. 2007; 29: 213–217. DOI: 10.1159/000112463
    Back to article
  41. 41Benito-León J, Louis ED, Mitchell AJ, Bermejo-Pareja F. Elderly-onset essential tremor and mild cognitive impairment: a population-based study (NEDICES). Journal of Alzheimer’s Disease. 2011; 23: 727–735. DOI: 10.3233/JAD-2011-101572
    Back to article
  42. 42Balaban H, Altuntaş EE, Uysal İÖ, Şentürk İA, Topaktaş S. Audio-vestibular evaluation in patients with essential tremor. European Archives of Oto-Rhino-Laryngology. 2012; 269: 1577–1581. DOI: 10.1007/s00405-011-1801-x
    Back to article
  43. 43Yilmaz NH, Akbostanci MC, Yılmaz N. Sensorineural hearing loss in non-depressed essential tremor cases and controls: a clinical and audiometric study. Tremor and Other Hyperkinetic Movements. 2015; 5.
    Back to article
  44. 44Ghika A, Kyrozis A, Potagas C, Louis ED. Motor and non-motor features: differences between patients with isolated essential tremor and patients with both essential tremor and Parkinson’s disease. Tremor and Other Hyperkinetic Movements. 2015; 5.
    Back to article
  45. 45Sabag AD, Dagan O, Avraham KB. Connexins in hearing loss: a comprehensive overview. Journal of basic and clinical physiology and pharmacology. 2005; 16: 101–116. DOI: 10.1515/JBCPP.2005.16.2-3.101
    Back to article
  46. 46Martinez AD, Acuña R, Figueroa V, Maripillan J, Nicholson B. Gap-junction channels dysfunction in deafness and hearing loss. Antioxidants & redox signaling. 2009; 11: 309–322. DOI: 10.1089/ars.2008.2138
    Back to article
  47. 47Kim AH, Nahm E, Sollas A, Mattiace L, Rozental R. Connexin 43 and hearing: possible implications for retrocochlear auditory processing. The Laryngoscope. 2013; 123: 3185–3193. DOI: 10.1002/lary.24249
    Back to article
  48. 48Shepherd GM. Perception without a thalamus: how does olfaction do it? Neuron. 2005; 46: 166–168. DOI: 10.1016/j.neuron.2005.03.012
    Back to article
  49. 49Hüttenbrink KB, Hummel T, Berg D, Gasser T, Hähner A. Olfactory dysfunction: common in later life and early warning of neurodegenerative disease. Deutsches Ärzteblatt International. 2013; 110: 1–7. DOI: 10.3238/arztebl.2013.0001
    Back to article
  50. 50Martínez NA, Carrillo GA, Alvarado PS, García CM, Monroy AV, Campos FV. Clinical importance of olfactory function in neurodegenerative diseases. Revista Médica del Hospital General de México. 2018; 81: 268–275. DOI: 10.1016/j.hgmx.2017.05.007
    Back to article
  51. 51Leboucq N, Menjot de Champfleur N, Menjot de Champfleur S, Bonafé A. Le système olfactif. Journal de Radiologie Diagnostique et Interventionnelle. 2013; 94(10): 992–999. DOI: 10.1016/j.jradio.2013.04.005
    Back to article
  52. 52Albers MW, Tabert MH, Devanand DP. Olfactory dysfunction as a predictor of neurodegenerative disease. Current neurology and neuroscience reports. 2006; 6: 379–386. DOI: 10.1007/s11910-996-0018-7
    Back to article
  53. 53Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. The Laryngoscope. 1984; 94: 176–178. DOI: 10.1288/00005537-198402000-00004
    Back to article
  54. 54Kovács T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing research reviews. 2004; 3: 215–232. DOI: 10.1016/j.arr.2003.10.003
    Back to article
  55. 55Oliveira-Pinto AV, Santos RM, Coutinho RA, Oliveira LM, Santos GB, Alho AT, Leite RE, Farfel JM, Suemoto CK, Grinberg LT, Pasqualucci CA. Sexual dimorphism in the human olfactory bulb: females have more neurons and glial cells than males. PloS one. 2014; 9: e111733. DOI: 10.1371/journal.pone.0111733
    Back to article
  56. 56Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Archives of neurology. 1998; 55: 84–90. DOI: 10.1001/archneur.55.1.84
    Back to article
  57. 57Field T. Smell and taste dysfunction as early markers for neurodegenerative and neuropsychiatric diseases. J Alzheimers Dis Parkinsonism. 2015; 5: 2161–0460.
    Back to article
  58. 58Kim HY. Olfaction and Neurodegenerative Disease. Hanyang Med Rev. 2014; 34: 116–119. DOI: 10.7599/hmr.2014.34.3.116
    Back to article
  59. 59Hüttenbrink KB, Hummel T, Berg D, Gasser T, Hähner A. Olfactory dysfunction: common in later life and early warning of neurodegenerative disease. Dtsch Arztebl Int. 2013; 110: 1–7. DOI: 10.3238/arztebl.2013.0001
    Back to article
  60. 60Hawkes C. Olfaction in neurodegenerative disorder. Movement disorders: official journal of the Movement Disorder Society. 2003; 18: 364–372. DOI: 10.1002/mds.10379
    Back to article
  61. 61Barresi M, Ciurleo R, Giacoppo S, Cuzzola VF, Celi D, Bramanti P, Marino S. Evaluation of olfactory dysfunction in neurodegenerative diseases. Journal of the neurological sciences. 2012; 323: 16–24. DOI: 10.1016/j.jns.2012.08.028
    Back to article
  62. 62Albers MW, Tabert MH, Devanand DP. Olfactory dysfunction as a predictor of neurodegenerative disease. Current neurology and neuroscience reports. 2006; 6: 379–386. DOI: 10.1007/s11910-996-0018-7
    Back to article
  63. 63Doty RL. Olfactory dysfunction in Parkinson disease. Nature Reviews Neurology. 2012; 8: 329–339. DOI: 10.1038/nrneurol.2012.80
    Back to article
  64. 64Doty RL, Deems DA, Stellar S. Olfactory dysfunction in Parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988; 38: 1237–1244. DOI: 10.1212/WNL.38.8.1237
    Back to article
  65. 65Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR. Association of olfactory dysfunction with risk for future Parkinson’s disease. Annals of neurology. 2008; 63: 167–173. DOI: 10.1002/ana.21291
    Back to article
  66. 66Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Movement disorders. 2007; 22: 839–842. DOI: 10.1002/mds.21413
    Back to article
  67. 67Zou YM, Lu D, Liu LP, Zhang HH, Zhou YY. Olfactory dysfunction in Alzheimer’s disease. Neuropsychiatr Dis Treat. 2016; 12: 869–875. DOI: 10.2147/NDT.S104886
    Back to article
  68. 68Connelly T, Farmer JM, Lynch DR, Doty RL. Olfactory dysfunction in degenerative ataxias. Journal of Neurology, Neurosurgery & Psychiatry. 2003; 74: 1435–1437. DOI: 10.1136/jnnp.74.10.1435
    Back to article
  69. 69Sobel N, Prabhakaran V, Hartley CA, Desmond JE, Zhao Z, Glover GH, Gabrieli JD, Sullivan EV. Odorant-induced and sniff-induced activation in the cerebellum of the human. Journal of Neuroscience. 1998; 18: 8990–9001. DOI: 10.1523/JNEUROSCI.18-21-08990.1998
    Back to article
  70. 70Houlden H. Sniffing out the cerebellum. J Neurol Neurosurg Psychiatry. 2012; 83: 952–953. DOI: 10.1136/jnnp-2012-303136
    Back to article
  71. 71Mainland JD, Johnson BN, Khan R, Ivry RB, Sobel N. Olfactory impairments in patients with unilateral cerebellar lesions are selective to inputs from the contralesional nostril. Journal of Neuroscience. 2005; 25: 6362–6371. DOI: 10.1523/JNEUROSCI.0920-05.2005
    Back to article
  72. 72García LI, García-Bañuelos P, Aranda-Abreu GE, Herrera-Meza G, Coria-Avila GA, Manzo J. Activation of the cerebellum by olfactory stimulation in sexually naive male rats. Neurología (English Edition). 2015; 30: 264–269. DOI: 10.1016/j.nrleng.2014.02.004
    Back to article
  73. 73Velázquez-Pérez L, Fernandez-Ruiz J, Díaz R, Pérez-González R, Ochoa NC, Cruz GS, Mederos LE, Góngora EM, Hudson R, Drucker-Colin R. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. Journal of neurology. 2006; 253: 1165–1169. DOI: 10.1007/s00415-006-0183-2
    Back to article
  74. 74Abele M, Riet A, Hummel T, Klockgether T, Wüllner U. Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. Journal of neurology. 2003; 250: 1453–1455. DOI: 10.1007/s00415-003-0248-4
    Back to article
  75. 75Braga-Neto P, Felicio AC, Pedroso JL, Dutra LA, Bertolucci PH, Gabbai AA, Barsottini OG. Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3. Parkinsonism & related disorders. 2011; 17: 353–356. DOI: 10.1016/j.parkreldis.2011.02.004
    Back to article
  76. 76Galvez V, Diaz R, Hernandez-Castillo CR, Campos-Romo A, Fernandez-Ruiz J. Olfactory performance in spinocerebellar ataxia type 7 patients. Parkinsonism & related disorders. 2014; 20: 499–502. DOI: 10.1016/j.parkreldis.2014.01.024
    Back to article
  77. 77Moscovich M, Munhoz RP, Teive HA, Raskin S, de J Carvalho M, Barbosa ER, Ranvaud R, Liu J, McFarland K, Ashizawa T, Lees AJ. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012; 83: 970–974. DOI: 10.1136/jnnp-2012-302770
    Back to article
  78. 78Moscovich M, Munhoz RP, Moro A, Raskin S, McFarland K, Ashizawa T, Teive HA, Silveira-Moriyama L. Olfactory Function in SCA10. The Cerebellum. 2019; 18: 85–90. DOI: 10.1007/s12311-018-0954-1
    Back to article
  79. 79Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC. Olfactory function in essential tremor. Neurology. 1992; 42: 1631–1631. DOI: 10.1212/WNL.42.8.1631
    Back to article
  80. 80Louis ED, Bromley SM, Jurewicz EC, Watner D. Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology. 2002; 59: 1631–1633. DOI: 10.1212/01.WNL.0000033798.85208.F2
    Back to article
  81. 81Applegate LM, Louis ED. Essential tremor: mild olfactory dysfunction in a cerebellar disorder. Parkinsonism & related disorders. 2005; 11: 399–402. DOI: https://doi.org/10.1016/j.parkreldis.2005.03.003
    Back to article
  82. 82Louis ED, Jurewicz EC. Olfaction in essential tremor patients with and without isolated rest tremor. Movement disorders: official journal of the Movement Disorder Society. 2003; 18: 1387–1389. DOI: 10.1002/mds.10603
    Back to article
  83. 83Louis ED, Rios E, Pellegrino KM, Jiang W, Factor-Litvak P, Zheng W. Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor. Neurotoxicology. 2008; 29: 460–465. DOI: 10.1016/j.neuro.2008.02.013
    Back to article
  84. 84Shah M, Muhammed N, Findley LJ, Hawkes CH. Olfactory tests in the diagnosis of essential tremor. Parkinsonism & related disorders. 2008; 14: 563–568. DOI: 10.1016/j.parkreldis.2007.12.006
    Back to article
  85. 85Quagliato LB, Viana MA, Quagliato EM, Simis S. Olfaction and essential tremor. Arquivos de neuro-psiquiatria. 2009; 67: 21–24. DOI: 10.1590/S0004-282X2009000100006
    Back to article
  86. 86Djaldetti R, Nageris BI, Lorberboym M, Treves TA, Melamed E, Yaniv E. [123 I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor. Journal of neural transmission. 2008; 115: 469–472. DOI: 10.1007/s00702-007-0851-0
    Back to article
  87. 87Silveira-Moriyama L, Schwingenschuh P, O’Donnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). Journal of Neurology, Neurosurgery & Psychiatry. 2009; 80: 744–748. DOI: 10.1136/jnnp.2009.172825
    Back to article
  88. 88Mckinnon J, Evidente V, Driver-Dunckley E, Premkumar A, Hentz J, Shill H, Sabbagh M, Caviness J, Connor D, Adler C. Olfaction in the elderly: a cross-sectional analysis comparing Parkinson’s disease with controls and other disorders. International Journal of Neuroscience. 2010; 120: 36–39. DOI: 10.3109/00207450903428954
    Back to article
  89. 89Wu Y, Wang X, Wang C, Sun Q, Song N, Zhou Y, Jiang Q, Qiao Y, Xu J, Liang L, Tang H. Prevalence and clinical features of non-motor symptoms of essential tremor in Shanghai rural area. Parkinsonism & related disorders. 2016; 22: 15–20. DOI: 10.1016/j.parkreldis.2015.10.617
    Back to article
  90. 90Bradvica IŠ, Mihaljević I, Butković-Soldo S, Kadojić D, Titlić M, Bradvica M, Kralik K. Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson’s disease and essential tremor. Neurological Sciences. 2015; 36: 1403–1410. DOI: 10.1007/s10072-015-2152-y
    Back to article
DOI: https://doi.org/10.5334/tohm.57 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Apr 6, 2020
Accepted on: Apr 13, 2020
Published on: Jun 9, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
essential tremor,
non-motor features,
sensory deficit,
hearing impairment,
olfactory dysfunction,
neurodegenerative disease

© 2020 Yildizhan Sengul, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 10 (2020): Issue 0Next article